Cargando…
Identification of a novel chalcone derivative that inhibits Notch signaling in T-cell acute lymphoblastic leukemia
Notch signaling is considered a rational target in the therapy of several cancers, particularly those harbouring Notch gain of function mutations, including T-cell acute lymphoblastic leukemia (T-ALL). Although currently available Notch-blocking agents are showing anti-tumor activity in preclinical...
Autores principales: | Mori, Mattia, Tottone, Luca, Quaglio, Deborah, Zhdanovskaya, Nadezda, Ingallina, Cinzia, Fusto, Marisa, Ghirga, Francesca, Peruzzi, Giovanna, Crestoni, Maria Elisa, Simeoni, Fabrizio, Giulimondi, Francesca, Talora, Claudio, Botta, Bruno, Screpanti, Isabella, Palermo, Rocco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438367/ https://www.ncbi.nlm.nih.gov/pubmed/28526832 http://dx.doi.org/10.1038/s41598-017-02316-9 |
Ejemplares similares
-
Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL
por: Tottone, Luca, et al.
Publicado: (2019) -
Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives
por: Zhdanovskaya, Nadezda, et al.
Publicado: (2021) -
Identification of a Novel Curcumin Derivative Influencing Notch Pathway and DNA Damage as a Potential Therapeutic Agent in T-ALL
por: Zhdanovskaya, Nadezda, et al.
Publicado: (2022) -
Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein response
por: Giuli, Maria Valeria, et al.
Publicado: (2020) -
Inhibition of Hedgehog-dependent tumors and cancer stem cells by a newly identified naturally occurring chemotype
por: Infante, Paola, et al.
Publicado: (2016)